Caseware UK (AP4) 2024.0.164 2024.0.164 2025-08-312025-08-31falsetrue2024-09-01falseResearch and experimental development on biotechnology98trueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 13576323 2024-09-01 2025-08-31 13576323 2023-09-01 2024-08-31 13576323 2025-08-31 13576323 2024-08-31 13576323 c:Director2 2024-09-01 2025-08-31 13576323 d:PlantMachinery 2024-09-01 2025-08-31 13576323 d:PlantMachinery 2025-08-31 13576323 d:PlantMachinery 2024-08-31 13576323 d:PlantMachinery d:OwnedOrFreeholdAssets 2024-09-01 2025-08-31 13576323 d:ComputerEquipment 2024-09-01 2025-08-31 13576323 d:ComputerEquipment 2025-08-31 13576323 d:ComputerEquipment 2024-08-31 13576323 d:ComputerEquipment d:OwnedOrFreeholdAssets 2024-09-01 2025-08-31 13576323 d:OtherPropertyPlantEquipment 2024-09-01 2025-08-31 13576323 d:OtherPropertyPlantEquipment 2025-08-31 13576323 d:OtherPropertyPlantEquipment 2024-08-31 13576323 d:OtherPropertyPlantEquipment d:OwnedOrFreeholdAssets 2024-09-01 2025-08-31 13576323 d:OwnedOrFreeholdAssets 2024-09-01 2025-08-31 13576323 d:CurrentFinancialInstruments 2025-08-31 13576323 d:CurrentFinancialInstruments 2024-08-31 13576323 d:Non-currentFinancialInstruments 2025-08-31 13576323 d:Non-currentFinancialInstruments 2024-08-31 13576323 d:CurrentFinancialInstruments d:WithinOneYear 2025-08-31 13576323 d:CurrentFinancialInstruments d:WithinOneYear 2024-08-31 13576323 d:Non-currentFinancialInstruments d:AfterOneYear 2025-08-31 13576323 d:Non-currentFinancialInstruments d:AfterOneYear 2024-08-31 13576323 d:ShareCapital 2025-08-31 13576323 d:ShareCapital 2024-08-31 13576323 d:SharePremium 2025-08-31 13576323 d:SharePremium 2024-08-31 13576323 d:OtherMiscellaneousReserve 2025-08-31 13576323 d:OtherMiscellaneousReserve 2024-08-31 13576323 d:RetainedEarningsAccumulatedLosses 2025-08-31 13576323 d:RetainedEarningsAccumulatedLosses 2024-08-31 13576323 c:OrdinaryShareClass1 2024-09-01 2025-08-31 13576323 c:OrdinaryShareClass1 2025-08-31 13576323 c:OrdinaryShareClass1 2024-08-31 13576323 c:OrdinaryShareClass2 2024-09-01 2025-08-31 13576323 c:OrdinaryShareClass2 2025-08-31 13576323 c:OrdinaryShareClass2 2024-08-31 13576323 c:OrdinaryShareClass3 2024-09-01 2025-08-31 13576323 c:OrdinaryShareClass3 2025-08-31 13576323 c:FRS102 2024-09-01 2025-08-31 13576323 c:AuditExempt-NoAccountantsReport 2024-09-01 2025-08-31 13576323 c:FullAccounts 2024-09-01 2025-08-31 13576323 c:PrivateLimitedCompanyLtd 2024-09-01 2025-08-31 13576323 e:PoundSterling 2024-09-01 2025-08-31 iso4217:GBP xbrli:shares xbrli:pure

Registered number: 13576323









STEMBOND TECHNOLOGIES LTD







UNAUDITED

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 AUGUST 2025

 
STEMBOND TECHNOLOGIES LTD
REGISTERED NUMBER: 13576323

BALANCE SHEET
AS AT 31 AUGUST 2025

2025
2024
Note
£
£

FIXED ASSETS
  

Tangible assets
 4 
27,302
19,997

  
27,302
19,997

CURRENT ASSETS
  

Debtors: amounts falling due within one year
 5 
178,443
9,297

Cash at bank and in hand
  
203,183
130,986

  
381,626
140,283

Creditors: amounts falling due within one year
 6 
(175,024)
(17,027)

NET CURRENT ASSETS
  
 
 
206,602
 
 
123,256

TOTAL ASSETS LESS CURRENT LIABILITIES
  
233,904
143,253

Creditors: amounts falling due after more than one year
 7 
-
(368,000)

  

NET ASSETS/(LIABILITIES)
  
233,904
(224,747)


CAPITAL AND RESERVES
  

Called up share capital 
 8 
2
1

Share premium account
  
1,575,733
-

Other reserves
  
-
550,000

Profit and loss account
  
(1,341,831)
(774,748)

  
233,904
(224,747)


Page 1

 
STEMBOND TECHNOLOGIES LTD
REGISTERED NUMBER: 13576323
    
BALANCE SHEET (CONTINUED)
AS AT 31 AUGUST 2025

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




A C Hodgson
Director

Date: 9 December 2025

The notes on pages 3 to 8 form part of these financial statements.

Page 2

 
STEMBOND TECHNOLOGIES LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2025

1.


GENERAL INFORMATION

Stembond Technologies Ltd is a private company limited by shares and was incorporated in England and Wales. The registered office address is Salisbury House, Station Road, Cambridge, CB1 2LA.

The functional and presentational currency is GBP.

2.ACCOUNTING POLICIES

 
2.1

BASIS OF PREPARATION OF FINANCIAL STATEMENTS

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

GOING CONCERN

The financial statements have been prepared on the going concern basis which assumes that the Company will continue as a going concern for the forseeable future. The trading losses reported to date are consistent with the Comapny's business plan as it progresses its research and development activities.

Given the investment received, together with the development progress achieved, the directors have a reasonable expectation that the Company will be able to meet its liabilities as they fall due for the forseeable future and therefore continue to adopt the going concern basis.

 
2.3

FOREIGN CURRENCY TRANSLATION

Functional and presentation currency

The Company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss except when deferred in other comprehensive income as qualifying cash flow hedges.

Foreign exchange gains and losses that relate to borrowings and cash and cash equivalents are presented in the Profit and Loss Account within 'finance income or costs'. All other foreign exchange gains and losses are presented in profit or loss within 'other operating income'.

Page 3

 
STEMBOND TECHNOLOGIES LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2025

2.ACCOUNTING POLICIES (CONTINUED)

 
2.4

REVENUE

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Sale of goods

Revenue from the sale of goods is recognised when all of the following conditions are satisfied:
the Company has transferred the significant risks and rewards of ownership to the buyer;
the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the transaction; and
the costs incurred or to be incurred in respect of the transaction can be measured reliably.

 
2.5

OPERATING LEASES: THE COMPANY AS LESSEE

Rentals paid under operating leases are charged to profit or loss on a straight-line basis over the lease term.

Benefits received and receivable as an incentive to sign an operating lease are recognised on a straight-line basis over the lease term, unless another systematic basis is representative of the time pattern of the lessee's benefit from the use of the leased asset.

 
2.6

RESEARCH AND DEVELOPMENT

Research and development expenditure is recognised in the Profit and Loss Account in the period in which the expenditure is incurred.

 
2.7

PENSIONS

DEFINED CONTRIBUTION PENSION PLAN

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance Sheet. The assets of the plan are held separately from the Company in independently administered funds.

Page 4

 
STEMBOND TECHNOLOGIES LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2025

2.ACCOUNTING POLICIES (CONTINUED)

 
2.8

TAXATION

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.


 
2.9

TANGIBLE FIXED ASSETS

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Plant and machinery
-
3 years straight line
Computer equipment
-
3 years straight line
Other fixed assets
-
3 years straight line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.10

DEBTORS

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.11

CASH AND CASH EQUIVALENTS

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.12

CREDITORS

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Page 5

 
STEMBOND TECHNOLOGIES LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2025

3.


EMPLOYEES

The average monthly number of employees, including directors, during the year was 9 (2024 - 8).


4.


TANGIBLE FIXED ASSETS





Plant and machinery
Computer equipment
Other fixed assets
Total

£
£
£
£



COST OR VALUATION


At 1 September 2024
954
14,026
22,301
37,281


Additions
-
2,465
18,909
21,374



At 31 August 2025

954
16,491
41,210
58,655



DEPRECIATION


At 1 September 2024
583
6,844
9,857
17,284


Charge for the year on owned assets
318
4,742
9,009
14,069



At 31 August 2025

901
11,586
18,866
31,353



NET BOOK VALUE



At 31 August 2025
53
4,905
22,344
27,302



At 31 August 2024
371
7,182
12,444
19,997

Page 6

 
STEMBOND TECHNOLOGIES LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2025

5.


DEBTORS

2025
2024
£
£


Other debtors
166,579
4,260

Prepayments and accrued income
11,864
5,037

178,443
9,297



6.


CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025
2024
£
£

Trade creditors
9,541
1,991

Other taxation and social security
10,394
-

Other creditors
125,796
1,620

Accruals and deferred income
29,293
13,416

175,024
17,027



7.


CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

2025
2024
£
£

Other creditors
-
368,000


Other creditors includes an amount of £NIL (2024 - £293,000) received as an investment for future share capital.

Page 7

 
STEMBOND TECHNOLOGIES LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2025

8.


SHARE CAPITAL

2025
2024
£
£
ALLOTTED, CALLED UP AND FULLY PAID



1,076,636 (2024 - 1,071,428) Ordinary shares of £0.000001 each
1
1
166,667 (2024 - 166,667) Deferred shares of £0.000001 each
-
-
1,098,262 (2024 - ) A1 Ordinary shares of £0.000001 each
1
-

2

1


On 28 Nov 2024 605,654 A1 Ordinary £0.000001 shares were issues at £1.03 per shares.

On 28 Nov 2024 488,599 A1 Ordinary £0.000001 shares were issues at £1.93 per shares.

On 16 Febuary 2025 5,208 Ordinary £0.000001 shares were issues at £0.000002 per shares.

On 18 March 2025 4,009 A1 Ordinary £0.000001 shares were issues at £1.93 per shares.

 
Page 8